1. Home
  2. OLOX vs VBIO Comparison

OLOX vs VBIO Comparison

Compare OLOX & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Olenox Industries Inc. Common Stock

OLOX

Olenox Industries Inc. Common Stock

N/A

Current Price

$0.88

Market Cap

1.4M

ML Signal

N/A

Logo Valion Bio Inc. Common Stock

VBIO

Valion Bio Inc. Common Stock

N/A

Current Price

$2.30

Market Cap

1.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
OLOX
VBIO
Founded
2007
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4M
1.6M
IPO Year
2011
2021

Fundamental Metrics

Financial Performance
Metric
OLOX
VBIO
Price
$0.88
$2.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.3M
23.1M
Earning Date
06-12-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,952,578.00
$780,000.00
Revenue This Year
$1,628.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.45
$0.11
52 Week High
$11.40
$4.14

Technical Indicators

Market Signals
Indicator
OLOX
VBIO
Relative Strength Index (RSI) 17.89 55.54
Support Level $0.58 $0.30
Resistance Level $1.14 $4.14
Average True Range (ATR) 0.26 0.59
MACD 0.04 0.09
Stochastic Oscillator 3.40 51.91

Price Performance

Historical Comparison
OLOX
VBIO

About OLOX Olenox Industries Inc. Common Stock

Olenox Industries Inc provides modular structures made from code-engineered cargo shipping containers as permanent or temporary structures for residential housing, commercial structures, and industrial applications. Its segments are: Construction, Software-as-a-Service (SaaS), Oil and Gas, and Others. Construction segment generates maximum revenue and designs and constructs modular structures in its factory using recycled shipping containers; in the past, traditional wood and steel frames were also used. It markets its construction products to contractors, home builders, building owners, other resellers, large multinational corporations, government agencies, private developers, the U.S. Military, individual homeowners, and pop-up retailers across the continental United States and Canada.

About VBIO Valion Bio Inc. Common Stock

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Share on Social Networks: